journal
https://read.qxmd.com/read/39249581/the-efficacy-of-rituximab-in-the-treatment-of-iga-vasculitis-nephritis
#21
REVIEW
Yi Xiong, Santiago Cuevas, Gaosi Xu, Honghong Zou
The utility of Rituximab (RTX) for IgA vasculitis nephritis (IgAVN) is not well established. Up to now, we analysed the largest samples of IgAVN patients treated by RTX with a total of 41 retrieved subjects up to December 29, 2023 in the present systematic review. We assessed the clinical profiles, efficacy, and safety of RTX treatments. The present review showed that the renal function tended to be stabilized (P = 1.000) and urinalysis tended to normalize after RTX treatment with no serious adverse events reported...
September 9, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39249558/apobec-family-reshapes-the-immune-microenvironment-and-therapy-sensitivity-in-clear-cell-renal-cell-carcinoma
#22
JOURNAL ARTICLE
Guiying Huang, Xianlin Zhan, Lihong Shen, Luping Lou, Yuehong Dai, Aiming Jiang, Yuzhen Gao, Yanzhong Wang, Xinyou Xie, Jun Zhang
Emerging evidence suggests that the APOBEC family is implicated in multiple cancers and might be utilized as a new target for cancer detection and treatment. However, the dysregulation and clinical implication of the APOBEC family in clear cell renal cell cancer (ccRCC) remain elusive. TCGA multiomics data facilitated a comprehensive exploration of the APOBEC family across cancers, including ccRCC. Remodeling analysis classified ccRCC patients into two distinct subgroups: APOBEC family pattern cancer subtype 1 (APCS1) and subtype 2 (APCS2)...
September 9, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39249542/modest-survival-benefits-of-autologous-stem-cell-transplantation-in-multiple-myeloma-with-renal-impairment-a-critical-appraisal-of-the-pre-antibody-era
#23
JOURNAL ARTICLE
Yan Li, Xinyi Zhang, Zhongqing Zou, Yanqiu Xiong, Xinyuan Gu, Ruiji Zou, Jing Tan, Li Zhang, Yuhuan Zheng, Ting Niu
The benefit of high-dose melphalan followed by autologous hematopoietic stem cell transplantation (HDM-ASCT) for multiple myeloma (MM) patients with renal insufficiency (RI) is debated. A systematic review and meta-analysis were conducted to assess the safety and efficacy of HDM-ASCT in MM patients with RIs, and the findings were compared with real-world data. The study included 26 articles, 13 of which were pooled for meta-analysis. We compared three different types of MM patients with RI against MM patients with normal renal function (NRF)...
September 9, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39249163/toxicity-profiles-of-immune-checkpoint-inhibitors-in-nervous-system-cancer-a-comprehensive-disproportionality-analysis-using-fda-adverse-event-reporting-system
#24
JOURNAL ARTICLE
Rongrong Liu, Hui Zhao, Zenghong Lu, Lingshuai Zeng, Huaqiu Shi, Longqiu Wu, Jing Wang, Fangjun Zhong, Chuanjian Liu, Yu Zhang, Zhengang Qiu
BACKGROUND: Immune-related adverse events (irAEs) always occur during treatment with immune checkpoint inhibitors (ICIs). Patients with nervous system cancer (NSC) may gain clinical benefit from ICIs, but irAEs in NSC patients are rarely examined. Therefore, our study systematically summarized reports of irAEs in NSC. METHODS: We obtained information from the FDA adverse event reporting system from the first quarter (Q1) of 2013 to the fourth quarter (Q4) of 2022...
September 9, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39249157/diagnostic-value-of-microrna-200-expression-in-peripheral-blood-derived-extracellular-vesicles-in-early-stage-non-small-cell-lung-cancer
#25
JOURNAL ARTICLE
Lina Liu, Fan Zhang, Dongling Niu, Xuan Guo, Ting Lei, Hongli Liu
OBJECTIVE: This study assessed the diagnostic value of microRNA-200 (miR-200) expression in peripheral blood-derived extracellular vesicles (EVs) in early-stage non-small cell lung cancer (NSCLC). METHODS: This study retrospectively analyzed 100 healthy volunteers (the control group) receiving physical examinations, 168 early-stage NSCLC patients (the NSCLC group), and 128 patients with benign lung nodules (the benign group). The basic and clinical data of participants were obtained, including age, sex, smoking history, carbohydrate antigen 242 (CA242), carcinoembryonic antigen (CEA), carbohydrate antigen 199 (CA199), forced expiratory volume in 1 s, maximal voluntary ventilation, forced vital capacity, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and miR-200 expression...
September 9, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39230837/enhanced-platelet-function-through-car-t-cell-therapy-in-relapsed-refractory-multiple-myeloma
#26
JOURNAL ARTICLE
Ruixue Ma, Qi Zhang, Yang Liu, Hujun Li, Huimin Chen, Qianqian Zhang, Jianlin Qiao, Kunming Qi, Guifang Shen, Cai Sun, Xuguang Song, Jiang Cao, Hai Cheng, Feng Zhu, Zhiling Yan, Wei Sang, Depeng Li, Haiying Sun, Junnian Zheng, Zhenyu Li, Kailin Xu, Wei Chen
The influence of chimeric antigen receptor T (CAR-T) cell therapy on platelet function in relapsed/refractory (R/R) multiple myeloma (MM) has not been thoroughly investigated. Our cohort comprised fifty MM patients treated with CAR-T cells. The mean platelet closure time (PCT) induced by collagen/adenosine diphosphate (CADP) in peripheral blood was significantly prolonged before lymphodepletion (195.24 ± 11.740 s) and notably reduced post-CAR-T cell therapy (128.02 ± 5...
September 4, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39230790/helicobacter-pylori-in-oral-cavity-current-knowledge
#27
REVIEW
Liana Cristina Melo Carneiro Costa, Maria das Graças Carvalho, Filipa F Vale, Andreia T Marques, Lucas Trevizani Rasmussen, Tsute Chen, Melina Barros-Pinheiro
The oral cavity may play a role as a reservoir and in the transmission and colonization of Helicobacter pylori. The route of transmission for H. pylori is not fully understood. The prevalence of this pathogen varies globally, affecting half of the world's population, predominantly in developing countries. Here, we review the prevalence of H. pylori in the oral cavity, the characteristics that facilitate its colonization and dynamics in the oral microbiome, the heterogeneity and diversity of virulence of among strains, and noninvasive techniques for H...
September 4, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39230721/anca-associated-vasculitis-and-lung-cancer-an-immunological-perspective
#28
REVIEW
Longzhao Li, Jun Teng, Na Kou, Yuan Yue, HongWu Wang
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a severe autoimmune disease that often involves the upper and lower respiratory tracts. In recent years, numerous studies have found a significant increase in the incidence of cancer among AAV patients, but the association between lung cancer and AAV remains inconclusive, with relatively low clinical attention. This review summarizes the current literature on the risk of lung cancer in patients with ANCA-associated vasculitis (AAV), detailing the potential mechanisms by which AAV may contribute to lung cancer, and further elucidates the inherent carcinogenic risks of immunosuppressants...
September 4, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39230623/investigation-of-pre-and-postoperative-th1-th2-cytokine-balance-and-novel-cytokines-in-colorectal-cancer-patients
#29
JOURNAL ARTICLE
Emre Gülçek, Yunushan Furkan Aydoğdu, Umut İhsan Emreol, Emin Ümit Bağrıaçık, Nusret Akyürek
Colorectal cancer (CRC) is a major health problem worldwide and is usually detected in advanced stages, although it is highly treatable with early detection. The aim of this study was to examine the serum levels of various cytokines involved in the pathogenesis of CRC. The study included 29 patients and 30 healthy volunteers. Blood samples were collected twice from the patient group, before and after surgery, and these samples were evaluated for interleukin (IL) 4, 10, 23r, 37, 38, 40 and interferon (IFN) gamma levels...
September 4, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39230596/diagnostic-accuracy-of-the-neutrophil-to-lymphocyte-ratio-and-the-platelet-to-lymphocyte-ratio-in-rheumatoid-arthritis-a-systematic-review-and-meta-analysis
#30
REVIEW
Arduino A Mangoni, Angelo Zinellu
Existing challenges with the early diagnosis of rheumatoid arthritis (RA) and active disease, mainly by non-rheumatologists, have prompted the search for novel biomarkers. Elevations in indices derived from blood cell counts, e.g., the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR), have been reported in RA patients. However, their diagnostic accuracy has not been comprehensively assessed. Therefore, we conducted a systematic review and meta-analysis of studies reporting the sensitivity and specificity of the NLR and PLR, obtained by receiver operating characteristic (ROC) curve analysis, for the presence of RA and active disease...
September 4, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39207564/tesc-associated-with-poor-prognosis-enhances-cancer-stemness-and-migratory-properties-in-liver-cancer
#31
JOURNAL ARTICLE
Peng Ye, Shahang Luo, Junyu Huang, Xihua Fu, Xiaoxia Chi, Jong-Ho Cha, Yumei Chen, Yanjun Mai, Kai-Wen Hsu, Xiuwen Yan, Wen-Hao Yang
Liver cancer stem cells (LCSCs) are responsible for recurrence, metastasis, and drug resistance in liver cancer. However, the genes responsible for inducing LCSCs have not been fully identified. Based on our previous study, we found that tescalcin (TESC), a calcium-binding EF hand protein that plays a crucial role in chromatin remodeling, transcriptional regulation, and epigenetic modifications, was up-regulated in LCSCs of spheroid cultures. By searching the Cancer Genome Atlas, International Cancer Genome Consortium, Human Protein Atlas, and Kaplan-Meier Plotter databases, we found that TESC expression was significantly elevated in liver cancer compared with that in normal liver tissue and was predictive of a decreased overall survival rate...
August 29, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39196452/profile-of-immunological-biomarkers-in-behcet-s-syndrome-a-large-scale-single-center-real-world-study
#32
JOURNAL ARTICLE
Jiachen Li, Feng Sun, Yingni Li, Jing Zhao, Rulin Jia, Hongyan Wang, Xiaohong Xiang, Xiaolin Sun, Chengbin Chen, Haixin Xu, Zhanguo Li, Tian Liu
Behcet's syndrome (BS) is a vasculitis characterized by immune dysregulation. Biomarkers are valuable for assessing clinically atypical pathogenesis. We aimed to investigate the distribution of different biomarkers and their effects on the clinical features of patients with BS in a large-scale, real-world study. This is a retrospective, single-center study. In total, 502 patients diagnosed with BS were enrolled in this study. We analyzed the clinical features of this cohort and divided patients' symptoms into six categories, including mucocutaneous, articular, neurological, gastrointestinal, vascular, and ocular involvements...
August 28, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39196444/viral-vector-based-therapeutic-hpv-vaccines
#33
REVIEW
Teng Ji, Yuchuan Liu, Yutong Li, Chuanfen Li, Yingyan Han
Replication-defective viral vector vaccines have several advantages over conventional subunit vaccines, including potent antibody responses, cellular responses critical for eliminating pathogen-infected cells, and the induction of highly immunogenic and durable immune responses without adjuvants. The Human papillomavirus (HPV), a microorganism with over 200 genotypes, plays a crucial role in inducing human tumors, with the majority of HPV-related malignancies expressing HPV proteins. Tumors associated with HPV infection, most of which result from HPV16 infection, include those affecting the cervix, anus, vagina, penis, vulva, and oropharynx...
August 28, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39196439/comments-about-high-ppp4c-expression-predicts-poor-prognosis-in-diffuse-large-b-cell-lymphoma
#34
LETTER
Qixin Liu, Ziheng Peng
No abstract text is available yet for this article.
August 28, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39196428/advances-in-nucleic-acid-therapeutics-structures-delivery-systems-and-future-perspectives-in-cancer-treatment
#35
REVIEW
Leqi Zhang, Wenting Lou, Jianwei Wang
Cancer has emerged as a significant threat to human health. Nucleic acid therapeutics regulate the gene expression process by introducing exogenous nucleic acid fragments, offering new possibilities for tumor remission and even cure. Their mechanism of action and high specificity demonstrate great potential in cancer treatment. However, nucleic acid drugs face challenges such as low stability and limited ability to cross physiological barriers in vivo. To address these issues, various nucleic acid delivery vectors have been developed to enhance the stability and facilitate precise targeted delivery of nucleic acid drugs within the body...
August 28, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39196415/oncolytic-virus-and-tumor-associated-macrophage-interactions-in-cancer-immunotherapy
#36
REVIEW
Marc Lecoultre, Paul R Walker, Aya El Helali
Oncolytic viruses (OV) are a promising strategy in cancer immunotherapy. Their capacity to promote anti-tumoral immunity locally raises hope that cancers unresponsive to current immunotherapy approaches could be tackled more efficiently. In this context, tumor-associated macrophages (TAM) must be considered because of their pivotal role in cancer immunity. Even though TAM tend to inhibit anti-tumoral responses, their ability to secrete pro-inflammatory cytokines and phagocytose cancer cells can be harnessed to promote therapeutic cancer immunity...
August 28, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39196406/elevated-tyg-bmi-index-predicts-incidence-of-chronic-kidney-disease
#37
JOURNAL ARTICLE
Cheng Fan, Mengyuan Guo, Shuye Chang, Zhaohui Wang, Tianhui An
Chronic kidney disease (CKD) represents a significant global public health issue, with its incidence and prevalence escalating annually. Metabolic disorders are one of the major etiological factors of CKD. This study investigates the relationship between the emerging metabolic index triglyceride-glucose body mass index (TyG-BMI) and the onset of CKD. Our study enrolled 3,485 healthy participants (1,576 men and 1,909 women), with a follow-up period of 3 years. The primary outcome was the emergence of CKD, defined by an eGFR less than 60 mL/(min × 1...
August 28, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39196390/il-21-and-cxcl9-engineered-gpc3-specific-car-t-cells-combined-with-pd-1-blockade-enhance-cytotoxic-activities-against-hepatocellular-carcinoma
#38
JOURNAL ARTICLE
Shanshan Chen, Fusheng Gong, Shijia Liu, Yunqing Xie, Xingming Ye, Xiaowei Lin, Xiangru Wang, Qiuhong Zheng, Qinying Liu, Yang Sun
The application of CAR-T cells in solid tumors poses several challenges, including poor T cell homing ability, limited infiltration of T cells and an immunosuppressive tumor environment. In this study, we developed a novel approach to address these obstacles by designing GPC3-specific CAR-T cell that co-express IL-21 and CXCL9 (21 × 9 GPC3 CAR-T cells) and blocking the PD-1 expression on it. The proliferation, cell phenotype, cytokine secretion and cell migration of indicated CAR-T cells were evaluated in vitro...
August 28, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39180670/sysmex-xn-hpc-study-of-reference-intervals-and-clinical-decision-limits-in-healthy-allogeneic-donors-mobilised-with-g-csf
#39
JOURNAL ARTICLE
Lunhui Huang, Binbin Lin, Yueyi Mu, Yong Li, Miao Chen, Yunxia Zhou, Guoqing Zhu, Erlie Jiang, Yonghui Xia
The Sysmex XN series haematopoietic progenitor cell (XN-HPC) is a novel tool for assessing stem cell yield before allogeneic haematopoietic stem cell transplantation. This study aimed to establish a reference interval (RI) for XN-HPC in peripheral blood allogeneic transplant donors following granulocyte colony-stimulating factor (G-CSF) stimulation and determine its clinical significance. All specimens were analysed using Sysmex XN-20. Samples were collected and analysed using non-parametric percentile methods to define the RIs...
August 24, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/39180586/clinical-significance-of-flc-tests-in-patients-without-other-evidence-of-hematologic-disorder
#40
JOURNAL ARTICLE
Dor Shpitzer, Yael C Cohen, Chava Perry, Guy Melamed, Hillel Alapi, Anat Reiner-Benaim, Irit Avivi
The clinical significance of an abnormal free light chain (FLC) test, performed due to unspecific complains in the absence of a known plasma cell dyscrasia (PCD) or lymphoproliferative disease (LPD), is not fully elucidated. We investigated the importance of an abnormal FLC ratio (FLC-R) in this setting. Patients registered in the Maccabi Healthcare Services database, tested for FLC during 2007-2023 without previously documented PCD/LPD or increased total protein (TP) level, were reviewed. Demographics, co-morbidities, and laboratory tests were recorded...
August 24, 2024: Clinical and Experimental Medicine
journal
journal
38106
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.